Recruiting

Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

Poland

Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Silesian Voivodeship

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie, Cracow

Uniwersytecki Szpital Kliniczny W Poznaniu, Poznan

Medical University Of Warsaw, Warsaw